Credit Suisse Group restated their underperform rating on shares of Humanigen (NASDAQ:HGEN – Get Rating) in a report issued on Monday morning, Benzinga reports. The firm currently has a $0.50 price objective on the stock. Separately, Cantor Fitzgerald initiated coverage on Humanigen in a research report on Wednesday, January 11th. They set a neutral rating […]
Related Keywords
, Credit Suisse Group , York Mellon Corp , Cantor Fitzgerald , Humanigen Inc , Virtu Financial , Renaissance Technologies , Suisse Group , Get Rating , New York Mellon Corp , Humanigen Daily , Humanigen , Nasdaq Hgen , 3thgen , Medical , Reiterated Rating , Credit Suisse Group Ag ,
vimarsana.com © 2020. All Rights Reserved.